Management of blood transfusion services in low-resource countries.

accreditation blood transfusion services low- and middle-income countries quality management systems

Journal

Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606

Informations de publication

Date de publication:
Dec 2022
Historique:
revised: 04 10 2022
received: 06 09 2022
accepted: 12 10 2022
pubmed: 10 11 2022
medline: 15 12 2022
entrez: 9 11 2022
Statut: ppublish

Résumé

Enabling universal access to safe blood components should be a key component of every country's national healthcare strategy. This study aimed to assess the current status of infrastructure and resources of blood transfusion services (BTS) in low- and middle-income countries. A cross-sectional survey was designed to gather information on blood donations, components, redistribution, testing resources and quality management systems (QMSs). The survey was distributed to the International Society of Blood Transfusion members between October 2021 and November 2021. A total of 54 respondents from 20 countries responded to the survey. This included hospital-based BTS/blood centres (46%), national blood centres (11%)and national and regional blood services (11%). Voluntary non-remunerated, replacement and paid donors accounted for 94.2%, 84.6% and 21.1% of donations, respectively. Apheresis donation was available in 59.6% of institutions. National/regional criteria for redistribution of blood components were reported by 75.9% of respondents. Blood components incurred payment charges in 81.5% of respondents' institutions, and payments were borne by patients in 50% of them. Testing methods, such as manual (83%), semi-automated (68%) or fully automated (36.2%), were used either alone or in combination. QMSs were reported in 17 institutions, while accreditation and haemovigilance were reported in 12 and 8 countries, respectively. QMS was implemented in most of the countries despite the common use of paid donations and the lack of advanced testing. Efforts to overcome persistent challenges and wider implementation of patient blood management programmes are required.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Enabling universal access to safe blood components should be a key component of every country's national healthcare strategy. This study aimed to assess the current status of infrastructure and resources of blood transfusion services (BTS) in low- and middle-income countries.
MATERIALS AND METHODS METHODS
A cross-sectional survey was designed to gather information on blood donations, components, redistribution, testing resources and quality management systems (QMSs). The survey was distributed to the International Society of Blood Transfusion members between October 2021 and November 2021.
RESULTS RESULTS
A total of 54 respondents from 20 countries responded to the survey. This included hospital-based BTS/blood centres (46%), national blood centres (11%)and national and regional blood services (11%). Voluntary non-remunerated, replacement and paid donors accounted for 94.2%, 84.6% and 21.1% of donations, respectively. Apheresis donation was available in 59.6% of institutions. National/regional criteria for redistribution of blood components were reported by 75.9% of respondents. Blood components incurred payment charges in 81.5% of respondents' institutions, and payments were borne by patients in 50% of them. Testing methods, such as manual (83%), semi-automated (68%) or fully automated (36.2%), were used either alone or in combination. QMSs were reported in 17 institutions, while accreditation and haemovigilance were reported in 12 and 8 countries, respectively.
CONCLUSION CONCLUSIONS
QMS was implemented in most of the countries despite the common use of paid donations and the lack of advanced testing. Efforts to overcome persistent challenges and wider implementation of patient blood management programmes are required.

Identifiants

pubmed: 36349461
doi: 10.1111/vox.13373
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1375-1383

Informations de copyright

© 2022 International Society of Blood Transfusion.

Références

World Health Organization. Blood safety and availability report. Geneva: WHO; 2022.
Darbandi A, Mashati P, Yami A, Gharehbaghian A, Namini MT. Status of blood transfusion in World Health Organization-Eastern Mediterranean Region (WHO-EMR): successes and challenges. Transfus Apher Sci. 2017;56:448-53.
Custer B, Zou S, Glynn SA, Makani J, Tayou Tagny C, El Ekiaby M, et al. Addressing gaps in international blood availability and transfusion safety in low- and middle-income countries: a NHLBI workshop. Transfusion. 2018;58:1307-17.
Laperche S, Boukatou G, Kouegnigan L, Nébié Y, Boulahi MO, Tagny CT, et al. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion. 2009;49:1600-8.
Bloch EM, Shah A, Kaidarova Z, Laperche S, Lefrere JJ, van Hasselt J, et al. A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries. Vox Sang. 2014;107:333-42.
Weimer A, Tagny CT, Tapko JB, Gouws C, Tobian AAR, Ness PM, et al. Blood transfusion safety in sub-Saharan Africa: a literature review of changes and challenges in the 21st century. Transfusion. 2019;59:412-27.
Divkolaye N, Seighali F, Pourfathollah AA, Sibinga CTS. A country-wide comparison of cost recovery and financing systems of blood and blood products. East Mediterr Health J. 2019;25:104-10.
Jenny HE, Saluja S, Sood R, Raykar N, Kataria R, Tongaonkar R, et al. Access to safe blood in low-income and middle-income countries: lessons from India. BMJ Glob Health. 2017;2:e000167.
World Health Organization. The 2016 global status report on blood safety and availability. Geneva: WHO; 2017.
World Health Organization. Guidance on centralization of blood donation testing and processing. Geneva: WHO; 2021.
Hosseinifard Z, Abbasi B. The inventory centralization impacts on sustainability of the blood supply chain. Comput Operat Res. 2018;89:206-12.
Allain JP, Sarkodie F, Asenso-Mensah K, Owusu-Ofori S. Relative safety of first-time volunteer and replacement donors in West Africa. Transfusion. 2010;50:340-3.
Buyx AM. Blood donation, payment, and non-cash incentives: classical questions drawing renewed Interest. Transfus Med Hemother. 2009;36:329-39.
Glynn SA, Williams AE, Nass CC, Bethel J, Kessler D, Scott EP, et al. Attitudes toward blood donation incentives in the United States: implications for donor recruitment. Transfusion. 2003;43:7-16.
World Health Organization. Global status report on blood safety and availability. Geneva: WHO; 2017.
Bassuni WY, Blajchman MA, Al-Moshary MA. Why implement universal leukoreduction? Hematol Oncol Stem Cell Ther. 2008;1:106-23.
Denesiuk L, Richardson T, Nahirniak S, Clarke G. Implementation of a redistribution system for near-outdate red blood cell units. Arch Pathol Lab Med. 2006;130:1178-83.
Natukunda B, Schonewille H, van de Watering L, Brand A. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang. 2010;98:167-71.
Owusu-Ofori S, Temple J, Sarkodie F, Candotti D, Allain JP. Predonation testing of potential blood donors in resource-restricted settings. Transfusion. 2005;45:1542-3.
Dhingra N. International challenges of self-sufficiency in blood products. Transfus Clin Biol. 2013;20:148-52.
Kruk ME, Gage AD, Joseph NT, Danaei G, García-Saisó S, Salomon JA. Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries. Lancet. 2018;392:2203-12.
Shaw CD, Kutryba B, Braithwaite J, Bedlicki M, Warunek A. Sustainable healthcare accreditation: messages from Europe in 2009. Int J Qual Health Care. 2010;22:341-50.
Mate KS, Rooney AL, Supachutikul A, Gyani G. Accreditation as a path to achieving universal quality health coverage. Glob Health. 2014;10:68.
Purvis GP, Jacobs D, Kak N. International health care accreditation models and country experiences: introductory report on options for the Republic of South Africa. Pretoria: University Research Co, LLC; 2010.
Bateganya M, Hagopian A, Tavrow P, Luboga S, Barnhart S. Incentives and barriers to implementing national hospital standards in Uganda. Int J Qual Health Care. 2009;21:421-6.
Lane J, Barnhart S, Luboga S, Arudo J, Urassa D, Hagopian A. The emergence of hospital accreditation programs in East Africa: lessons from Uganda, Kenya, and Tanzania. Glob J Med Public Health. 2014;3:32-41.
Samukange WT, Kluempers V, Porwal M, Mudyiwenyama L, Mutoti K, Aineplan N, et al. Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal. BMC Health Serv Res. 2021;21:1258.
Meybohm P, Froessler B, Goodnough LT, Klein AA, Muñoz M, Murphy MF, et al. “Simplified international recommendations for the implementation of patient blood management”(SIR4PBM). Perioper Med. 2017;6:5.
Makani J, Lyimo M, Magesa P, Roberts DJ. Strengthening medical education in haematology and blood transfusion: postgraduate programmes in Tanzania. Br J Haematol. 2017;177:838-45.
Kesinger MR, Nagy LR, Sequeira DJ, Charry JD, Puyana JC, Rubiano AM. A standardized trauma care protocol decreased in-hospital mortality of patients with severe traumatic brain injury at a teaching hospital in a middle-income country. Injury. 2014;45:1350-4.
Eichbaum Q, Shan H, Goncalez TT, Duits AJ, Knox P, Reilly J, et al. Global health and transfusion medicine: education and training in developing countries. Transfusion. 2014;54:1893-8.

Auteurs

Gopal K Patidar (GK)

Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.

Jecko Thachil (J)

Department of Haematology, Manchester Royal Infirmary, Manchester, UK.

Yashaswi Dhiman (Y)

Department of Immunohematology & Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India.

Adaeze Oreh (A)

Department of Planning, Research and Statistics, National Blood Service Commission, Abuja, Nigeria.
Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands.

Hans Vrielink (H)

Department of Transfusion medicine, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.

Karin van den Berg (K)

Translational Research Department, Medical Division, South African National Blood Service, Port Elizabeth, South Africa.
Medical Division, South African National Blood Service, Roodepoort, South Africa.
Division of Clinical Haematology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Division of Clinical Haematology, University of the Free State, Bloemfontein, South Africa.

Rada M Grubovic Rastvorceva (RM)

Institute for Transfusion Medicine of RNM, Skopje, North Macedonia.
Department of Transfusion Medicine, Faculty of Medical Sciences, University Goce Delcev Stip, Macedonia, North Macedonia.

Cynthia So-Osman (C)

Department of Transfusion medicine, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.
Departmentof Haematology, Erasmus Medical Centre, Rotterdam, The Netherlands.

Arwa Z Al-Riyami (AZ)

Department of Hematology, Sultan Qaboos University Hospital, Muscat, Oman.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH